FILING DEADLINE--Kuznicki Law PLLC Announces Class Action On Behalf Of Shareholders Of Amylyx Pharmaceuticals, Inc. - AMLX
Date
4/3/2024 10:45:37 PM
(MENAFN- GlobeNewsWire - Nasdaq) CEDARHURST, N.Y., April 03, 2024 (GLOBE NEWSWIRE) -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Amylyx Pharmaceuticals, Inc. (NasdaqGS: AMLX), if they purchased the Company's securities between November 11, 2022 and November 8, 2023, inclusive (the“Class Period”). Shareholders have until April 9, 2024 to file lead plaintiff applications in the securities class action lawsuit.
Shareholders are encouraged to contact us at , by calling toll-free at 1-833-835-1495 or by email (...).
Kuznicki Law PLLC is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Kuznicki Law PLLC
Daniel Kuznicki, Esq.
445 Central Avenue, Suite 344
Cedarhurst, NY 11516
Email: ...
Phone: (347) 696-1134
Cell: (347) 690-0692
Fax: (347) 348-0967
MENAFN03042024004107003653ID1108056718
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.